Tevogen Bio Is Looking Forward to Closing Its Transaction With Semper Paratus
WARREN, N.J.--(BUSINESS WIRE)--Jan 31, 2024--
Stay updated with breaking news from Ryan Saadi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WARREN, N.J.--(BUSINESS WIRE)--Jan 31, 2024--
Tevogen Bio Inc. ("Tevogen Bio") today announced the appointment of Afshin Beheshti, PhD, to Tevogen's Advisory Board. Dr. Beheshti joined KBR at NASA Ames Research Center in 2017 to contribute to the GeneLab genetics database project. He currently...
05.01.2024 - The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen Bio”) stockholders is an expected $1.2 billion.Tevogen Bio is an advanced-stage specialty immunotherapy biotech pioneer developing ... Seite 1
Tevogen Bio Inc. (“Tevogen Bio”) is an advanced-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell...
FinancialContent fully hosted finance channel